Skip to main content

Table 3 Prescribed drugs and irrational usage in patients with congenital and acquired heart diseases (n = 853)

From: Drug use in children hospitalized with cardio-rheumatologic diseases in Andijan, Uzbekistan: a cross-sectional descriptive study

Classification of drugs Number of patients received drugs (%) Number of patients received irrational drugs (%)a
NSAIDsb 349 (40.9) 298 (85.4)
Diclofenac 143 (16.8) 142 (99.3)
SAIDsc 201 (23.6) 192 (95.5)
Prednisolone 159 (18.6) 153 (96.2)
Vitamins-microelements 686 (80.4) 157 (22.9)
Ascorbic acid 215 (25.2) 10 (4.7)
Aspartic acid 461 (54.0) 0
Antibiotics 532 (62.4) 470 (88.3)
Cephalosporins 293 (34.3) 220 (75.1)
Penicillins 234 (27.4) 216 (92.3)
Amoxicillin 134 (15.7) 134 (100)
Aminoglycosides 65 (7.6) 65 (100)
Macrolides 98 (11.5) 94 (95.9)
Sulfonamides 7 (0.8) 7 (100)
Lincosamides 3 (0.4) 2 (66.7)
Fluoroquinolones 1 (0.1) 1 (100)
Antihistamines 379 (44.4) 122 (32.2)
Broncholitics 42 (4.9) 33 (78.6)
Diuretics 310 (36.3) 134 (43.2)
Furosemide 288 (33.8) 115 (39.9)
Hydrochlorothiazide 1 (0.1) 1 (100)
Hydrochlorothiazide + triamteren 8 (0.9) 8 (100)
Antispasmodics 32 (3.8) 22 (68.8)
Cardiovascular drugs 542 (63.5) 477 (88.0)
Glycosides 374 (43.8) 374 (100)
Digoxin 373 (43.7) 373 (100)
ACE inhibitorsd 98 (11.5) 58 (59.2)
Captopril 91 (10.7) 58 (63.7)
β-adrenergic blocking agents 37 (4.3) 37 (100)
Propranolol 37 (4.3) 37 (100)
Other cardiovascular drugs 139 (16.3) 71 (51.1)
Bendazol 1 (0.1) 1 (100)
Piracetam + cinnarizin 4 (0.5) 4 (100)
Verapamil 1 (0.1) 1 (100)
Other drugs 327 (38.3) 221 (67.6)
Potassium orotas 115 (13.5) 115 (100)
  1. aOf those who received the drug
  2. bNon-steroid anti-inflammatory drugs
  3. cSteroid anti-inflammatory drugs
  4. dAngiotensin-converting enzyme inhibitors